Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 28022 | 176 | 25.7 | 85% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 39 | 32196 | MANTLE CELL LYMPHOMA//MYCOSIS FUNGOIDES//DIFFUSE LARGE B CELL LYMPHOMA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PLASMABLASTIC LYMPHOMA | Author keyword | 127 | 72% | 56% | 99 |
| 2 | PLASMABLASTIC | Author keyword | 17 | 79% | 6% | 11 |
| 3 | HUMAN IMMUNODEFICIENCY VIRUS NEGATIVE | Author keyword | 4 | 75% | 2% | 3 |
| 4 | ORAL CAVITY LYMPHOMA | Author keyword | 3 | 100% | 2% | 3 |
| 5 | MYC TRANSLOCATION | Author keyword | 1 | 100% | 1% | 2 |
| 6 | TERMINAL B CELL DIFFERENTIATION | Author keyword | 1 | 100% | 1% | 2 |
| 7 | ANAPLASTIC LARGE CELL LYMPHOMA KINASE | Author keyword | 1 | 50% | 1% | 1 |
| 8 | CARNIO IAL UNIT | Address | 1 | 50% | 1% | 1 |
| 9 | CD20 NEGATIVE | Author keyword | 1 | 50% | 1% | 1 |
| 10 | GASTROESOPHAGEAL NEOPLASM | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | VIRUS NEGATIVE PATIENT | 9 | 83% | 3% | 5 |
| 2 | HIV NEGATIVE PATIENT | 7 | 46% | 7% | 12 |
| 3 | HIV POSITIVE CHILD | 4 | 75% | 2% | 3 |
| 4 | POSITIVE CHILD | 1 | 100% | 1% | 2 |
| 5 | PLASMABLASTIC LYMPHOMA | 1 | 14% | 5% | 8 |
| 6 | CASTLEMAN DISEASE | 1 | 12% | 4% | 7 |
| 7 | MYELOMAS | 1 | 33% | 1% | 2 |
| 8 | ORAL PLASMABLASTIC LYMPHOMA | 1 | 50% | 1% | 1 |
| 9 | NEGATIVE PATIENT | 1 | 19% | 2% | 3 |
| 10 | PRIMARY EXTRAMEDULLARY PLASMACYTOMA | 0 | 20% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: A single institutional experience and literature review | 2011 | 30 | 28 | 93% |
| Plasmablastic Lymphoma: A Systematic Review | 2011 | 16 | 44 | 93% |
| Bortezomib in Plasmablastic Lymphoma: A Case Report and Review of the Literature | 2013 | 10 | 19 | 68% |
| The biology and treatment of plasmablastic lymphoma | 2015 | 1 | 53 | 47% |
| HIV-Negative Plasmablastic Lymphoma: Not in the Mouth | 2011 | 13 | 30 | 90% |
| Plasmablastic lymphoma of the small intestine: Case report and literature review | 2012 | 8 | 14 | 93% |
| Plasmablastic lymphoma of the oral cavity in a human immunodeficiency virus-negative patient: A case report with literature review | 2014 | 2 | 25 | 88% |
| Human immunodeficiency virus-negative plasmablastic lymphoma in the neck: a rare case report and literature review | 2014 | 1 | 21 | 90% |
| Primary gingival diffuse large B-cell lymphoma: a case report and a review of the literature | 2014 | 1 | 7 | 71% |
| Oral cavity and extra-oral plasmablastic lymphomas in AIDS patients: report of five cases and review of the literature | 2011 | 4 | 19 | 68% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CARNIO IAL UNIT | 1 | 50% | 0.6% | 1 |
| 2 | ICH STUDY | 1 | 50% | 0.6% | 1 |
| 3 | ROGER WILLIAMS HOSP | 1 | 25% | 1.1% | 2 |
| 4 | HEMATOL SICHUAN PROV | 0 | 33% | 0.6% | 1 |
| 5 | HEMATOPATHOL HEMATOL | 0 | 33% | 0.6% | 1 |
| 6 | TRANSFUS CELL TRANSPLANTAT | 0 | 33% | 0.6% | 1 |
| 7 | UNIV ENT 1 | 0 | 33% | 0.6% | 1 |
| 8 | DERMATOL MC 624 | 0 | 25% | 0.6% | 1 |
| 9 | FDN IFIMAV | 0 | 25% | 0.6% | 1 |
| 10 | ORAL MED MAXILLO IAL SURG | 0 | 25% | 0.6% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000290031 | AIDS RELATED LYMPHOMA//NON AIDS DEFINING CANCER//NON AIDS DEFINING CANCERS |
| 2 | 0.0000175295 | DIFFUSE LARGE B CELL LYMPHOMA//PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA//GRAY ZONE LYMPHOMA |
| 3 | 0.0000130781 | WALDEYERS RING//LARYNGEAL LYMPHOMA//TONSILLAR LYMPHOMA |
| 4 | 0.0000125618 | PRIMARY EFFUSION LYMPHOMA//KSHV//TUMOR VIROL PROGRAM |
| 5 | 0.0000109731 | RICHTERS SYNDROME//RICHTER SYNDROME//COMPOSITE LYMPHOMA |
| 6 | 0.0000086324 | ANAPLASTIC LARGE CELL LYMPHOMA//LYMPHOMATOID PAPULOSIS//NPM ALK |
| 7 | 0.0000083557 | PLASMA CELL LEUKEMIA//PRIMARY PLASMA CELL LEUKEMIA//MMSET |
| 8 | 0.0000081076 | PLASMACYTOMA//EXTRAMEDULLARY PLASMACYTOMA//SOLITARY PLASMACYTOMA |
| 9 | 0.0000075362 | POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER//PTLD//POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE |
| 10 | 0.0000071875 | CASTLEMANS DISEASE//CASTLEMAN DISEASE//ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA |